Ninds drug manufacturing and formulation program (dmfp)
Active Indefinite Delivery Contract Awarded Last action
- Contract number
- 75N98026D00012
- Awardee
-
Alchem Laboratories Corporation UEI LD2KY6H7KMQ5
- Awarding agency
-
Office of Logisitics and Acquisition Operations
National Institutes of Health, Department of Health and Human Services
- Task orders
- 0
Award facts
- Opportunity
-
- Drug Manufacturing and Formulation Program (DMFP) Pre-Solicitation · 75N95024R00077 · Posted May 3, 2024
- Last date to order 5% complete
- IDV ceiling
- $49,999,999.00
- Award type
- Multiple award
- Who can order
- Only the awarding agency
- Funding agency
- National Institute of Neurological Disorders and Stroke National Institutes of Health, Department of Health and Human Services
- NAICS code
- 325412 Pharmaceutical Preparation Manufacturing
- Set-aside
- No set-aside
- Competition
- Full and Open Competition · 7 offers Negotiated Proposal / Quote
- Pricing
- Order Dependent (IDV only)
- Legislative mandates
-
- Service Contract Act FAR subpart 22.10
- Employment Eligibility Verification (E-Verify) FAR subpart 22.18
- Service Contract Inventory FAR subpart 4.17
Award details come from SAM.gov/FPDS.
About this IDV
The National Institute of Neurological Disorders and Stroke awarded a multiple-award indefinite-delivery contract to Alchem Laboratories Corporation on May 4, 2026, with a $49,999,999 ceiling and an ultimate completion date of May 3, 2036. The contract carries no set-aside designation and was issued under full and open competition as part of the Drug Manufacturing and Formulation Program (DMFP), a component of the Blueprint Neurotherapeutics Network.
Alchem Laboratories will provide drug manufacturing and formulation services to support the advancement of candidate molecules toward clinical-stage development. Requested capabilities include active pharmaceutical ingredient (API) scale-up and manufacturing, formulation and dosage form manufacturing, analytical methods development, and stability testing. Place of performance is not specified in the source.
The originating solicitation, posted May 3, 2024 with a June 7, 2024 due date, anticipated multiple IDIQ awards with a ten-year ordering period and task order issuance for each DMFP project. The contract includes a Determination of Exceptional Circumstances allowing contributors to retain intellectual property rights for investigational agents evaluated through the DMFP.
Transactions
| Action | Obligated | Date |
|---|---|---|
| Other Administrative Action | $0 | |
| Original award | $0 |
Quick answers
Who was awarded contract 75N98026D00012?
75N98026D00012 was awarded to Alchem Laboratories Corporation by Office of Logisitics and Acquisition Operations (National Institutes of Health) on May 4, 2026.
How much is contract 75N98026D00012 worth?
75N98026D00012's own ceiling is $49,999,999.
Which agency awarded contract 75N98026D00012?
Office of Logisitics and Acquisition Operations (National Institutes of Health) awarded 75N98026D00012, with funding from National Institute of Neurological Disorders and Stroke (National Institutes of Health).
Who can order from contract 75N98026D00012?
75N98026D00012 is a multiple award indefinite delivery contract. Only the awarding agency can place orders on it.
Was contract 75N98026D00012 competed?
The extent of competition for 75N98026D00012 was full and open competition. The government received 7 offers.
On GovTribe
See this IDV's full record
- Every order and transaction
- The awardee's other awards and teaming partners
- Similar IDVs and recompete opportunities
- Ask GovTribe AI about this IDV